| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Head Of R&D, Coo-novitium Ops
1 company
Shanmugam Muthusamy is a Head Of R&D, Coo-novitium Ops at ANI PHARMACEUTICALS INC. Recent SEC Form 4 filings include 0 buys and 25 sells.
Estimated insider holdings value: $35.3M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 17, 2024 | ANIP Ani Pharmaceuticals Inc | Head Of R&D, Coo-novitium Ops | Sell | 22,768 | $65.91 | $1,500,589.42 | -0.9% | -1.9% | +5.7% | |
| Mar 8, 2024 | ANIP Ani Pharmaceuticals Inc | Head Of R&D, Coo-novitium Ops | Sell | 10,000 | $67.17 | $671,700.00 | -1.2% | +2.1% | -10.1% | |
| Mar 7, 2024 | ANIP Ani Pharmaceuticals Inc | Head Of R&D, Coo-novitium Ops | Sell | 40,000 | $65.77 | $2,630,863.64 | -1.5% | +0.4% | -9.1% | |
| Jan 23, 2024 | ANIP Ani Pharmaceuticals Inc | Head Of R&D, Coo-novitium Ops | Sell | 25,216 | $56.17 | $1,416,466.08 | -0.9% | +15.9% | +2.7% | |
| Jan 18, 2024 | ANIP Ani Pharmaceuticals Inc | Head Of R&D, Coo-novitium Ops | Sell | 24,784 | $55.29 | $1,370,305.20 | -0.9% | +17.8% | +5.2% | |
| Dec 19, 2023 | ANIP Ani Pharmaceuticals Inc | Head Of R&D, Coo-novitium Ops | Sell | 50,000 | $52.55 | $2,627,250.00 | -1.7% | +28.2% | +2.2% | |
| Nov 17, 2023 | ANIP Ani Pharmaceuticals Inc | Head Of R&D, Coo-novitium Ops | Sell | 13,000 | $51.00 | $663,000.00 | -1.3% | +12.0% | +10.1% | |
| Nov 16, 2023 | ANIP Ani Pharmaceuticals Inc | Head Of R&D, Coo-novitium Ops | Sell | 36,190 | $53.00 | $1,918,079.91 | -1.2% | +9.5% | +10.4% | |
| Oct 19, 2023 | ANIP Ani Pharmaceuticals Inc | Head Of R&D, Coo-novitium Ops | Sell | 25,000 | $57.75 | $1,443,868.50 | -0.8% | -3.0% | +5.2% | |
| Oct 16, 2023 | ANIP Ani Pharmaceuticals Inc | Head Of R&D, Coo-novitium Ops | Sell | 25,000 | $57.96 | $1,449,035.99 | -1.2% | -5.4% | +0.0% |